AN2 THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.475 USD | -3.32% |
|
+5.06% | -87.85% |
| 03/04 | North American Morning Briefing : Powell Awaited -2- | DJ |
| 02/04 | JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform | MT |
Chart calendar AN2 Therapeutics, Inc.
62a42dca5.SIAH26p-dOTyPAvfZxtde3mQCzfW1Xv5u5wlNvOOgUw.eu9ug9sKNqXFX36WCFRqFzTyWGCFtE6P3uVocL7n1nwXxHeK2AgV0J9xSg~53636c99ff62468cb16adb69675279dc
Upcoming events on AN2 Therapeutics, Inc.
Past events on AN2 Therapeutics, Inc.
| 29/03/2024 01:40 am | Q4 2023 Earnings Release |
| 14/02/2024 09:10 pm | Oppenheimer Healthcare Life Sciences Conference |
| 29/11/2023 07:15 pm | Evercore ISI HealthCONx Conference |
| 16/11/2023 01:30 am | Stifel Healthcare Conference |
| 10/11/2023 02:35 am | Q3 2023 Earnings Release |
| 14/10/2023 09:45 pm | IDWeek Conference - Poster No :2135 |
| 14/10/2023 09:45 pm | IDWeek Conference - Poster No :2556 |
| 14/10/2023 09:45 pm | IDWeek Conference - Poster No :2144 |
| 14/10/2023 08:24 pm | IDWeek Conference - Poster No :2064 |
| 12/10/2023 06:18 pm | IDWeek Conference - Poster No :32 |
| 11/08/2023 01:40 am | Q2 2023 Earnings Release |
| 09/06/2023 02:00 am | Jefferies Global Healthcare Conference |
| 07/06/2023 08:30 pm | Annual General Meeting |
| 16/05/2023 11:30 pm | JMP Securities Life Sciences Conference |
| 12/05/2023 01:40 am | Q1 2023 Earnings Release |
| 30/03/2023 01:31 am | Q4 2022 Earnings Release |
| 14/03/2023 08:50 pm | Oppenheimer Healthcare Conference |
| 07/03/2023 07:40 pm | Cowen Health Care Conference |
| 15/02/2023 03:30 am | SVB Securities Global Biopharma Conference |
| 01/12/2022 12:45 am | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -42,3 -41,6 -1.59% | -69,6 -70,9 1.74% | -79,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -64,7 -66,9 3.27% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -28,1 | -42,8 -43,1 0.67% | -64,7 -67,3 3.79% | -81,1 |
|
EPS USD | Released Forecast Spread | -25,0 | -2,79 -2,62 -6.35% | -2,74 -2,94 6.8% | -2,57 |
| Announcement Date | 04/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,68 -9,90 22.39% | -10,3 -11,5 9.76% | -11,8 -11,5 -2.79% | -12,5 -11,9 -5.28% | -16,0 -13,6 -17.93% | -16,6 -16,8 0.89% | -18,2 -16,2 -12.22% | -18,8 -20,1 6.22% | -19,4 | -19,6 | -19,8 | -20,3 | -20,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -19,1 11.48% | ||||||||||||
|
Net income Million USD | Released Forecast Spread | -9,48 -8,97 -5.67% | -10,1 -10,9 6.87% | -11,3 -11,9 4.45% | -11,8 -12,6 6.02% | -15,3 -13,3 -15.5% | -15,8 -16,7 5.18% | -16,7 -16,2 -3.13% | -16,9 -19,4 13% | -18,9 | -19,8 | -20,7 | -21,8 | -20,0 |
|
EPS USD | Released Forecast Spread | -2,98 -0,92 -224.8% | -0,53 -1,89 71.91% | -0,59 -0,59 0.56% | -0,61 -0,65 5.67% | -0,79 -0,68 -16.18% | -0,81 -0,85 5.08% | -0,65 -0,63 -3.72% | -0,57 -0,75 23.49% | -0,62 | -0,63 | -0,65 | -0,67 | -0,67 |
| Announcement Date | 10/05/22 | 11/08/22 | 09/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for AN2 Therapeutics, Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANTX Stock
- Calendar AN2 Therapeutics, Inc.